Volitionrx (VNRX) Debt to Equity (2019 - 2025)
Volitionrx's Debt to Equity history spans 8 years, with the latest figure at -$0.19 for Q4 2025.
- For Q4 2025, Debt to Equity fell 24.92% year-over-year to -$0.19; the TTM value through Dec 2025 reached -$0.19, down 24.92%, while the annual FY2025 figure was -$0.19, 24.92% down from the prior year.
- Debt to Equity reached -$0.19 in Q4 2025 per VNRX's latest filing, down from -$0.17 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.18 in Q3 2022 to a low of -$1.23 in Q1 2023.
- Average Debt to Equity over 5 years is -$0.13, with a median of -$0.19 recorded in 2025.
- The largest YoY upside for Debt to Equity was 793.65% in 2022 against a maximum downside of 810.32% in 2022.
- A 5-year view of Debt to Equity shows it stood at $0.17 in 2021, then tumbled by 810.32% to -$1.23 in 2022, then skyrocketed by 54.91% to -$0.55 in 2023, then soared by 72.7% to -$0.15 in 2024, then dropped by 24.92% to -$0.19 in 2025.
- Per Business Quant, the three most recent readings for VNRX's Debt to Equity are -$0.19 (Q4 2025), -$0.17 (Q3 2025), and -$0.19 (Q2 2025).